7478072

Source:http://linkedlifedata.com/resource/pubmed/id/7478072

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002726, umls-concept:C0003826, umls-concept:C1442792
pubmed:issue	7-8
pubmed:dateCreated	1995-12-15
pubmed:abstractText	Amyloidosis is characterized by a heterogeneous group of diseases due to deposition of a fibrillar, proteinaceous material, in different tissues. In this review pathogenetic mechanisms, clinical and therapeutic findings of the most important aspects of the disease, are described.
pubmed:language	ita
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0400732
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenal Cortex Hormones, http://linkedlifedata.com/resource/pubmed/chemical/Amyloid, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Azathioprine, http://linkedlifedata.com/resource/pubmed/chemical/Colchicine, http://linkedlifedata.com/resource/pubmed/chemical/Dimethyl Sulfoxide, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon Type I, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Serum Amyloid A Protein, http://linkedlifedata.com/resource/pubmed/chemical/Serum Amyloid P-Component
pubmed:status	MEDLINE
pubmed:issn	0026-4806
pubmed:author	pubmed-author:AmorosoAA, pubmed-author:Di MonacoCC, pubmed-author:Di RosaRR, pubmed-author:TanzilliOO
pubmed:issnType	Print
pubmed:volume	86
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	291-7
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:7478072-Administration, Topical, pubmed-meshheading:7478072-Adrenal Cortex Hormones, pubmed-meshheading:7478072-Amyloid, pubmed-meshheading:7478072-Amyloidosis, pubmed-meshheading:7478072-Anti-Bacterial Agents, pubmed-meshheading:7478072-Anti-Inflammatory Agents, pubmed-meshheading:7478072-Antineoplastic Agents, pubmed-meshheading:7478072-Azathioprine, pubmed-meshheading:7478072-Colchicine, pubmed-meshheading:7478072-Diagnosis, Differential, pubmed-meshheading:7478072-Dimethyl Sulfoxide, pubmed-meshheading:7478072-Humans, pubmed-meshheading:7478072-Immunosuppressive Agents, pubmed-meshheading:7478072-Interferon Type I, pubmed-meshheading:7478072-Middle Aged, pubmed-meshheading:7478072-Plasmapheresis, pubmed-meshheading:7478072-Prognosis, pubmed-meshheading:7478072-Recombinant Proteins, pubmed-meshheading:7478072-Serum Amyloid A Protein, pubmed-meshheading:7478072-Serum Amyloid P-Component
pubmed:articleTitle	[Amyloidosis: state of the art].
pubmed:publicationType	Comparative Study, Editorial, English Abstract